Archived Insight | March 25, 2021

How to Implement the ARPA's COBRA Premium Subsidy

The American Rescue Plan Act of 2021 (ARPA) provides a 100 percent subsidy of COBRA premiums beginning on April 1, 2021, through September 30, 2021, with subsidies being paid to plan sponsors through a payroll tax credit. The government is required to issue model notices required to be sent to participants concerning subsidy eligibility and a new election period no later than April 10, 2021.

This webinar which took place on April 13, 2021, explained how the subsidy works and discussed the guidance published by the government.

ARPA COBRA subsidy webinar

Watch the Webinar

 

Get the slides from this webinar

Don’t have time to watch a video right now? No worries. Here is a copy of the slides.

Download the Slides

Read more insights

Male Therapist Encourages Distressed Male Veteran

MHPAEA Litigation and Enforcement News

See the Mental Health Parity and Addiction Equity Act (MHPAEA) litigation on hold and enforcement considerations, plus next steps for plan sponsors.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Architecture Engineering & Construction, Higher Education, Mental Health

Read Full Insight

Lawyer And Business Person Discussing In The Office

Supreme Court Addresses Prohibited Transaction Lawsuits

As a result of the Supreme Court’s decision, it will be easier for participants to sue plans for everyday plan transactions with service providers.

Retirement, Compliance, Multiemployer Plans, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.